Research Specifications
- Class:
- Small molecule (non-peptide) ERR pan-agonist
- Developer:
- Burris Lab, Saint Louis University
- Presentation:
- 5 mg/mL in 30 mL vehicle (150 mg total)
- Form:
- Solution
- Purity:
- ≥98% verified
- Storage:
- 4°C; avoid light
SLU-PP-332 5mg/mL 30mL
ERR pan-agonist small molecule
CAS: 2095432-58-3
+70%
Running time to exhaustion
Billon 2023 (mouse)
3 receptors
Pan-ERR agonism
α/β/γ
Preclinical
Stage
No human trials
Receptor Targets
ERRα (NR3B1)Mitochondrial biogenesis, fatty acid oxidation gene program
ERRβ (NR3B2)Type I muscle fiber genes, oxidative metabolism
ERRγ (NR3B3)Cardiac and skeletal muscle oxidative capacity
$89.99In Stock
Buy Now ≥98% Purity Verified Free Shipping $200+ HPLC Tested
Preclinical
Preclinical exercise mimetic research
No human clinical trials published. All data from rodent models and in vitro assays.
Also Known As
SLU-PP-332ERR pan-agonistExercise mimetic (research term)Burris Lab ERR compound
Often Stacked With
Published References
- 1.Billon C, Canaple L, Fleury-Olela F, et al.. A synthetic ERR agonist alleviates metabolic syndrome. Journal of Pharmacology and Experimental Therapeutics (2023) PMID: 36958851
- 2.Giguère V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocrine Reviews (2008) PMID: 18436706
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $89.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds
Liquid Solutions
Capsules & Tablets
Capsules & Tablets
SLU-PP-332 5mg/mL 30mL
$89.99